# SpyGlass Surgical Study

> **NCT05822635** · — · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 34 (actual)

## Conditions studied

- Pancreatic Diseases
- Bile Duct Diseases
- Hepatic Disease

## Interventions

- **DEVICE:** SpyGlass Discover Digital System or SpyGlass DS Direct Visualization System

## Key facts

- **NCT ID:** NCT05822635
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-01
- **Primary completion:** 2024-12-04
- **Final completion:** 2025-01-03
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2025-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05822635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05822635, "SpyGlass Surgical Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05822635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*